期刊文献+

抑制GSK-3β活性促进NF-κB诱导的儿童急性淋巴细胞白血病细胞凋亡

Inhibition of Glycogen Synthase Kinase-3β Promotes NF-κB Induced-apoptosis in Pediatric Acute Lymphocyte Leukemia Cells
下载PDF
导出
摘要 核转录因子-κB(NF-κB)是维持急性淋巴细胞白血病(ALL)细胞生存的关键因子.近年来发现,糖原合成酶激酶-3β(GSK-3β)可以正性调控NF-κB的活性.本研究通过抑制GSK-3β活性初步探讨ALL细胞中GSK-3β在NF-κB诱导细胞凋亡中的作用机制.收集ALL患儿骨髓单个核细胞,采用免疫荧光细胞化学方法检测到ALL细胞核内GSK-3β有明显聚集.体外培养ALL细胞后经GSK-3β抑制剂氯化锂(LiCl)和SB216763处理,采用Western印迹和EMSA检测发现,ALL细胞核内GSK-3β表达下降,而NF-κBP65蛋白无明显变化,但是其活性明显降低.同时RT-PCR结果显示,NF-κB下游抗凋亡基因存活素(survivin)的表达随之下降,AnnexinV-PE/7-AAD双染流式细胞仪检测结果证实,ALL细胞凋亡明显增加(P<0.01).该结果表明,抑制GSK-3β活性可以下调NF-κB的转录活性,并通过下调抗凋亡基因存活素的表达而促进ALL细胞的凋亡. Nuclear factor-κB (NF-κB) is a key factor in acute lymphoblastic leukemia (ALL) cell survival,.Glycogen synthase kinase-3β (GSK-3β) has recently been found to positively regulate the activity of NF-κB. Here, we have explored the effect of GSK-3β inhibition on NF-κB-induced apoptosis in ALL cells. Mononuclear cells were isolated from the heparinized bone marrow of children with ALL by density gradient centrifugation. GSK-3β significantly accumulates in nuclei of ALL cells by immunofluorescence staining method. ALL cells were treated with GSK-3β inhibitors, lithium chloride (LiC1) or SB216763 in vitro, leading to decrease of its nuclear pool, and suppression NF-κB transcriptional activity by Western blot and EMSA analyses. Furthermore, we observed that GSK-3β inhibition resulted in a marked reduction in the expression of the NF-κB antiapoptotic target gene survivin by RT-PCR analysis, and a dose-dependent increase in the number of apoptotie cells by Annexin V-PE/ 7-AAD double staining flow cytometry. These results suggest that GSK-3β inhibition could down-regulate NF-κB transcriptional activity and the gene expression of survivin, holding the potential to enhance apoptosis in pediatric ALL ceils.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2010年第9期809-815,共7页 Chinese Journal of Biochemistry and Molecular Biology
关键词 糖原合成酶激酶-3Β 儿童急性淋巴细胞白血病 核转录因子-ΚB 存活素 细胞凋亡 glycogen synthase kinase-3β (GSK-3β) pediatric acute lymphocyte leukemia nuclearfaetor-κB (NF-κB) survivin cell apoptosis
  • 相关文献

参考文献17

  • 1Pui C H, Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia[ J]. Nat Rev Drug Discov,2007,6 (2) :149-165.
  • 2Weston V J, Austen B, Wei W, et al. Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-KB survival pathway signaling[ J]. Blood,2004,104( 5 ) : 1465-1473.
  • 3Ougolkov A V, Fernandez-Zapico M E, Savoy D N, et al. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells[ J]. Cancer Res ,2005,115(6) :2076-2081.
  • 4Aggarwa| B B. Nuclear factor-kappaB: the enemy within [ J ]. Cancer Cell,2004,6(3 ) :203-208.
  • 5郑丽端,童强松,杨渝珍,侯晓华,杨秀萍,董继华.NF-κB决定小鼠胎肝激酶-1基因启动子的基本活性[J].中国生物化学与分子生物学报,2007,23(8):625-630. 被引量:2
  • 6Hayden S M, Ghosh S. Shared principles in NF-KB signaling [ J ]. Cell,2008,132 ( 3 ) :344-362.
  • 7Steinbrecher K A, WiLson W, Cogswell P C, et al. Glycogen synthase kinase 3beta functions to specify gene-specific, NF- kappaB dependent transcription [ J ]. Mol Cell Biol, 2005,25 (19) :8444-8455.
  • 8曹琦,丰有吉.糖原合酶激酶-3β促进卵巢癌细胞增殖的实验研究[J].中华肿瘤杂志,2006,28(11):804-809. 被引量:3
  • 9Shakoori A, Ougolkov A, Yu Z W, et al. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation [ J ]. Biochem Biophys Res Commun, 2005,334 (4) : 1365-1373.
  • 10De T F, Racaud-Suhan C, Chicanne G, et al. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia [ J ]. Oncogene, 2006,25 ( 22 ) : 3113 -3122.

二级参考文献21

  • 1赵书君,刘俊英,任芬若,丰有吉.葡萄糖转运蛋白1在卵巢上皮性癌组织中的表达及其与碱性成纤维生长因子、增殖细胞核抗原表达的关系[J].中华妇产科杂志,2005,40(4):264-268. 被引量:10
  • 2Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol,2005, 202: 654-662.
  • 3Jope RS, Johnson GVW. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci, 2004, 29: 95-102.
  • 4Ougolkov AV, Fernandez-Zapico ME, Savoy DN, et al. Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res, 2005, 65:2076-2081.
  • 5Shakoofi A, Ougolkov A, Yu ZW, et al. Deregulated GSK3β activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun, 2005,334:1365-1373.
  • 6Meijer L, Flajolet M, Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci, 2004, 25:471-480.
  • 7Gatenby RA, Gawlinski ET. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res, 2003, 63 : 3847-3854.
  • 8Hoeflich KP, Luo J, Rubie EA, et al. Requirement for glycogen synthase kinase-313 in cell survival and NF-κB activation. Nature,2000, 406: 86-90.
  • 9Demarchi F, Bertoli C, Sandy P, et al. Glycogen synthase kinase-313 regulates NF-κB1/p105 stability. J Biol Chem, 2003, 278:39583 -39590.
  • 10Ferrara N,Gerber H P,LeCouter J.The biology of VEGF and its receptors[J].Nat Med,2003,9(6):669-676.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部